Research Topics
| Lars HolmbergSummaryAffiliation: Uppsala University Hospital Country: Sweden Publications
| Collaborators
|
Detail Information
Publications
The role of the primary-care physician in oncology care. Primary healthcare and specialist cancer servicesLars Holmberg
Regional Oncologic Centre, Uppsala, Sweden
Lancet Oncol 6:121-2. 2005
HABITS (hormonal replacement therapy after breast cancer--is it safe?), a randomised comparison: trial stoppedL Holmberg
Regional Oncologic Centre, University Hospital, SE 751 85 Uppsala, Sweden
Lancet 363:453-5. 2004..We decided that these findings indicated an unacceptable risk for women exposed to HRT in the HABITS trial, and the trial was terminated on Dec 17, 2003...
Radical prostatectomy versus watchful waiting in early prostate cancerAnna Bill-Axelson
Department of Urology, University Hospital, Uppsala, Sweden
N Engl J Med 364:1708-17. 2011..In 2008, we reported that radical prostatectomy, as compared with watchful waiting, reduces the rate of death from prostate cancer. After an additional 3 years of follow-up, we now report estimated 15-year results...
Radical prostatectomy versus watchful waiting in localized prostate cancer: the Scandinavian prostate cancer group-4 randomized trialAnna Bill-Axelson
Department of Urology, University Hospital, Uppsala, Sweden
J Natl Cancer Inst 100:1144-54. 2008..In 2005, we reported that radical prostatectomy improved prostate cancer survival compared with watchful waiting after a median of 8.2 years of follow-up. We now report results after 3 more years of follow-up...
Long-term quality-of-life outcomes after radical prostatectomy or watchful waiting: the Scandinavian Prostate Cancer Group-4 randomised trialEva Johansson
Department of Surgical Sciences, University Hospital of Uppsala, Uppsala, Sweden
Lancet Oncol 12:891-9. 2011..We report results for quality of life for men in the Scandinavian Prostate Cancer Group Study Number 4 (SPCG-4) after a median follow-up of more than 12 years...
Social differences in breast cancer survival in relation to patient management within a National Health Care System (Sweden)Sonja Eaker
Department of Surgery, Uppsala University, Uppsala, Sweden
Int J Cancer 124:180-7. 2009....
Serum levels of selenium and smoking habits at age 50 influence long term prostate cancer risk; a 34 year ULSAM follow-upBirgitta Grundmark
Department of Surgical Sciences, Uppsala University, Uppsala, Sweden
BMC Cancer 11:431. 2011..We investigated the relation between s-Se, smoking and non-screening detected PrCa and explored if polymorphisms in two DNA repair genes: OGG1 and MnSOD, influenced any effect of s-Se...
Time, symptom burden, androgen deprivation, and self-assessed quality of life after radical prostatectomy or watchful waiting: the Randomized Scandinavian Prostate Cancer Group Study Number 4 (SPCG-4) clinical trialEva Johansson
Department of Urology, Uppsala University Hospital, Uppsala, Sweden
Eur Urol 55:422-30. 2009..Quality-of-life outcomes are important in the choice of treatment strategy for men with localized prostate cancer...
Cyclin B is an immunohistochemical proliferation marker which can predict for breast cancer death in low-risk node negative breast cancerAnthoula Koliadi
Department of Oncology, Radiology and Clinical Immunology, Uppsala University, Uppsala, Sweden
Acta Oncol 49:816-20. 2010..Cyclin B is a proliferative marker easily assessed by immunohistochemistry. We wanted to examine cyclin B as a prognostic factor in low-risk breast cancer patients...
Borderline ovarian tumors in Sweden 1960-2005: trends in incidence and age at diagnosis compared to ovarian cancerIngiridur Skirnisdottir
Department of Women s and Children s Health, Obstetrics and Gynecology, Uppsala University, Uppsala, Sweden
Int J Cancer 123:1897-901. 2008....
Increased risk of recurrence after hormone replacement therapy in breast cancer survivorsLars Holmberg
Department of Surgical Sciences, Uppsala University, Uppsala, Sweden
J Natl Cancer Inst 100:475-82. 2008..We present results after extended follow-up...
Gene copy number aberrations are associated with survival in histologic subgroups of non-small cell lung cancerPatrick Micke
Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden
J Thorac Oncol 6:1833-40. 2011..To maximize the chance to identify clinically relevant events, we applied a strategy involving two prognostically extreme patient groups...
Differences in management of older women influence breast cancer survival: results from a population-based database in SwedenSonja Eaker
Regional Oncologic Centre ROC, University Hospital, SE 751 85 Uppsala, Sweden
PLoS Med 3:e25. 2006..We sought to investigate whether differences in the management of older women with breast cancer are associated with survival...
Season of diagnosis and prognosis in breast and prostate cancerLars Holmberg
Regional Oncologic Center and Department of Surgical Sciences, Uppsala University, Uppsala, Sweden
Cancer Causes Control 20:663-70. 2009..Patients with breast or prostate cancer diagnosed during the summer season have been observed to have better survival. The extent to which this is due to biological and/or health care system related factors is unclear...
Distribution of coronary artery stenosis after radiation for breast cancerGreger Nilsson
Uppsala University, University Hospital, SE 751 85 Uppsala, Sweden
J Clin Oncol 30:380-6. 2012..To study distribution of coronary artery stenosis among patients with breast cancer (BC) and to assess correlation between radiotherapy (RT) and location of stenosis...
Non-genital tract metastases to the ovaries presented as ovarian tumors in Sweden 1990-2003: occurrence, origin and survival compared to ovarian cancerIngiridur Skirnisdottir
Department of Women s and Children s Health, Obstetrics and Gynecology, Akademiska University Hospital, Uppsala, Sweden
Gynecol Oncol 105:166-71. 2007..Origin of metastases and time of detection in relation to surgery were recorded. Age at diagnosis, survival for ovarian metastasis compared to ovarian cancer and prognostic factors were evaluated...
Prognostic markers under watchful waiting and radical prostatectomyLars Holmberg
Regional Oncologic Center, University Hospital, Uppsala, Sweden
Hematol Oncol Clin North Am 20:845-55. 2006..Because overall prognostic information obtained by these parameters or by tumor stage was not provided in our publication, we now present these data in the two study arms separately...
Regional differences in breast cancer survival despite common guidelinesSonja Eaker
Department of Surgery, Regional Oncologic Centre, University Hospital of Uppsala, SE 751 85 Uppsala, Sweden
Cancer Epidemiol Biomarkers Prev 14:2914-8. 2005..We therefore examined breast cancer survival in relation to differences in diagnostic activity, tumor characteristics, and treatment in seven Swedish counties within a single health care region...
Experiences of randomization: interviews with patients and clinicians in the SPCG-IV trialAnna Bill-Axelson
Department of Urology, Uppsala University Hospital, Uppsala, Sweden
Scand J Urol Nephrol 42:358-63. 2008..This study investigated patients' and clinicians' experiences of randomization with the aim of facilitating trial participation in the future...
The metabolic syndrome and the risk of prostate cancer under competing risks of death from other causesBirgitta Grundmark
Regional Oncologic Centre, Uppsala University Hospital, Uppsala, Sweden
Cancer Epidemiol Biomarkers Prev 19:2088-96. 2010..Using the National Cholesterol Education Program Adult Treatment panel III (NCEP) and International Diabetes Federation (IDF) definitions of the MetS, we investigated such associations taking competing risks of death into consideration...
Radical prostatectomy versus watchful waiting in early prostate cancerAnna Bill-Axelson
Department of Urology, University Hospital, Uppsala, Sweden
N Engl J Med 352:1977-84. 2005..In 2002, we reported the initial results of a trial comparing radical prostatectomy with watchful waiting in the management of early prostate cancer. After three more years of follow-up, we report estimated 10-year results...
Birth outcome in women with previously treated breast cancer--a population-based cohort study from SwedenKristina Dalberg
Department of Surgery and the Regional Oncologic Centre, Uppsala University Hospital, Uppsala, Sweden
PLoS Med 3:e336. 2006..The aim of this study was to assess the risk of adverse birth outcomes in women previously treated for invasive breast cancer compared with the general population of mothers...
Survival endpoints in colorectal cancer and the effect of second primary other cancer on disease free survivalHelgi Birgisson
Department of Surgical Sciences, Colorectal Surgery, Uppsala University, Uppsala, Sweden
BMC Cancer 11:438. 2011..The aim of this study was to compare different survival endpoints in patients with primary colorectal cancer (CRC) and to understand the effect of second primary other cancer on disease-free survival (DFS) calculations...
Regional differences in treatment and outcome in non-small cell lung cancer: a population-based study (Sweden)Gunnar Myrdal
Department of Thoracic and Cardiovascular Surgery, Uppsala University Hospital, Uppsala, Sweden
Lung Cancer 63:16-22. 2009..Despite common guidelines there were marked differences in treatment activity between the counties. Treatment activity was associated with survival. Survival benefits may follow improvement in compliance to guidelines...
Reducing cancer drug doses in obese patients: dogma disputedLars Holmberg
Regional Oncologic Centre, University Hospital, S-751 85 Uppsala, Sweden
Lancet 366:1056-7. 2005
Neoadjuvant cisplatinum based combination chemotherapy in patients with invasive bladder cancer: a combined analysis of two Nordic studiesAmir Sherif
Department of Urology, Akademiska University Hospital, SE 751 85 Uppsala, Sweden
Eur Urol 45:297-303. 2004..We analyzed overall survival in all patients and in prespecified subgroups defined by preoperative T-stage, gender and age...
Cyclin A is a proliferative marker with good prognostic value in node-negative breast cancerCecilia Ahlin
Department of Oncology, Uppsala University Hospital, SE 751 85 Uppsala, Sweden
Cancer Epidemiol Biomarkers Prev 18:2501-6. 2009..Studies suggest that cyclin A is a prognostic marker with satisfying reproducibility. We investigated cyclin A as a prognostic marker in node-negative breast cancer using previously defined cutoff values. Patients and..
CD99 is a novel prognostic stromal marker in non-small cell lung cancerKarolina Edlund
Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden
Int J Cancer 131:2264-73. 2012..The results support the concept that stromal properties have an important impact on tumour progression...
Increased incidence of stroke in women with breast cancerGreger Nilsson
Section of Oncology, Department of Oncology, Radiology and Clinical Immunology, University Hospital, SE 751 85 Uppsala, Sweden
Eur J Cancer 41:423-9. 2005..A statistically significant increase in the risk of stroke was seen among women with a history of breast cancer. Whether this risk is associated with the breast cancer disease per se or related to any treatment requires further study...
Plasma vitamin D and mortality in older men: a community-based prospective cohort studyKarl Michaelsson
Department of Surgical Sciences and Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden
Am J Clin Nutr 92:841-8. 2010..Vitamin D status is known to be important for bone health but may also affect the development of several chronic diseases, including cancer and cardiovascular diseases, which are 2 major causes of death...
Breast-conserving surgery without radiotherapyL Holmberg
Department of Surgery, University Hospital, Uppsala, Sweden
Acta Oncol 34:681-3. 1995..4) If the long-term--positive and negative--effects of radiotherapy were better quantified. Until we have new information, postoperative radiotherapy after breast conservation remains the standard...
Radiation to supraclavicular and internal mammary lymph nodes in breast cancer increases the risk of strokeG Nilsson
Department of Oncology, Radiology and Clinical Immunology, University Hospital, Uppsala, Sweden
Br J Cancer 100:811-6. 2009..Our finding of a target-specific increased risk of stroke and a dose-response relationship for daily fraction dose, indicate that there may be a causal link between RT to the IMC and SCL and risk of stroke...
Pre-operative oestradiol levels - relation to survival in breast cancerL Holmberg
Department of Surgery, University Hospital, Uppsala, MA, S 751 85, Sweden
Eur J Surg Oncol 27:152-6. 2001..However, few studies have information on plasma levels of hormones pre-operatively...
Age as a determinant of axillary node involvement in invasive breast cancerL Holmberg
Department of Surgery, University Hospital, Uppsala, Sweden
Acta Oncol 31:533-8. 1992..The findings indicate that the parallelism between the establishment of metastases in lymph nodes and at distant sites may vary with age. The prognostic value of nodal status may therefore depend on age at diagnosis...
Ductal carcinoma in situ of the breast: a new phenotype classification system and its relation to prognosisF Warnberg
Department of Surgery, University Hospital, Uppsala, Sweden
Breast Cancer Res Treat 73:215-21. 2002....
Five-node biopsy of the axilla: an alternative to axillary dissection of levels I-II in operable breast cancerJ Ahlgren
Department of Oncology, University Hospital, Uppsala, S-751 85, Sweden
Eur J Surg Oncol 28:97-102. 2002..Five-node biopsy is an alternative to axillary clearance and sentinel node biopsy in patients with operable breast cancer. Copyright Harcourt Publishers Limited...
Risk factors for subsequent invasive breast cancer and breast cancer death after ductal carcinoma in situ: a population-based case-control study in SwedenF Warnberg
Department of Surgery, University Hospital, S 751 85 Uppsala, Sweden
Cancer Epidemiol Biomarkers Prev 10:495-9. 2001..The driving forces behind local and generalized disease may differ. Because confounding by indication may influence the effects of different treatments, the results should be interpreted with caution...
Failure to detect early breast cancer using in vitro nuclear magnetic resonance spectroscopy of plasmaL Holmberg
Department of Surgery, University Hospital, Uppsala, Sweden
Br J Cancer 68:389-92. 1993..7 Hz). In vitro NMR spectroscopy in our hands was thus not a useful diagnostic tool in patients with early breast cancer...
Defining a high mortality risk group among women with primary breast cancerT Norden
Department of Surgery, University Hospital, Uppsala, Sweden
Br J Cancer 69:520-4. 1994..Women with no involved nodes and with three or four negative factors had a risk of dying from breast cancer similar to that of node-positive women with fewer than three...
Role of surgery in invasive breast cancerL Holmberg
Department of Surgery, University Hospital, Uppsala, Sweden
Acta Oncol 34:625-8. 1995....
Prognosis in bilateral breast cancer. Effects of time interval between first and second primary tumoursL Holmberg
Department of Surgery, University Hospital, Uppsala, Sweden
Br J Cancer 58:191-4. 1988..The results indicate that the two tumours contribute independently to the patient's excess risk of dying and thus occur as two seemingly biologically unrelated events with respect to the tumour-host relationship and metastatic behaviour...
Sector resection with and without radiotherapy in early breast cancer. Presentation of two ongoing prospective multicenter studies in Sweden. Uppsala/Orebro Breast Cancer Study GroupL Holmberg
Department of Surgery, University Hospital, Uppsala, Sweden
Acta Oncol 28:927-9. 1989..Overall 5% of the women in the conservatively treated group and 22% of the mastectomized women are still suffering substantial psychosocial disturbance after 13 months...
Preoperative serum levels of follicle stimulating hormone (FSH) and prognosis in invasive breast cancerM Eskelinen
Regional Oncologic Center and Department of Surgery, University of Uppsala, Uppsala, Sweden
Eur J Surg Oncol 30:495-500. 2004..Today, FSH is not a clinical target for intervention or a clinically useful prognostic factor and the results of clinical studies up to date can only be used for motivation of further experimental laboratory research...
Active surveillance for early-stage prostate cancer: review of the current literatureMarc A Dall'Era
Department of Urology, University of California at San Francisco Comprehensive Cancer Center, University of California at San Francisco, San Francisco, California 94143 1695, USA
Cancer 112:1650-9. 2008..The best candidates for active surveillance are being defined, as are predictors of active treatment. The psychosocial ramifications of surveillance for prostate cancer can be profound and future needs and unmet goals will be discussed...
Coffee, tea, and caffeine consumption and breast cancer incidence in a cohort of Swedish womenKarin B Michels
Obstetrics and Gynecology Epidemiology Center, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA
Ann Epidemiol 12:21-6. 2002..04 (95% CI 0.87-1.24) compared to women in the lowest quintile. CONCLUSIONS: In this large cohort of Swedish women, consumption of coffee, tea, and caffeine was not associated with breast cancer incidence...
[Registries contribute to better breast cancer care]Leif Bergkvist
, Centrallasarettet,
Lakartidningen 101:2579-81. 2004
Prostate-specific antigen levels as a predictor of lethal prostate cancerKatja Fall
Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Box 281, S 171 77 Stockholm, Sweden
J Natl Cancer Inst 99:526-32. 2007..Rates of long-term survival among patients with untreated localized prostate cancer are high. To avoid unnecessary treatment, tools are needed to identify the small proportion of patients who are destined to develop lethal prostate cancer...
Determinants of cancer patients' utilization of hospital care within two years after diagnosisBirgitta B K Johansson
Department of Oncology, Radiology and Clinical Immunology, the Section of Caring Sciences, Uppsala University, Sweden
Acta Oncol 43:536-44. 2004..The results suggest that thorough assessment can identify patients at diagnosis with an increased need for follow-up, e.g. intensified home care services...
Ductal carcinoma in situ of the breast with different histopathological grades and corresponding new breast tumour events: analysis of loss of heterozygosityJohanna Smeds
Department of Oncology Pathology, Radiumhemmet Cancer Centre Karolinska, Karolinska Institute and Hospital, S 171 76 Stockholm, Sweden
Acta Oncol 44:41-9. 2005..Also observed was a complete heterogeneity of LOH in the primary DCIS and their corresponding new events, suggesting that these events probably developed from genetically divergent clones...
SweDCIS: Radiotherapy after sector resection for ductal carcinoma in situ of the breast. Results of a randomised trial in a population offered mammography screeningStefan O Emdin
Department of Surgery, Umea University Hospital, Umea, Sweden
Acta Oncol 45:536-43. 2006..Women undergoing sector resection for DCIS under conditions of population based screening mammography benefit from postoperative RT to the breast. Seven patients needed RT-treatment to prevent one recurrence...
Gene expression profiling spares early breast cancer patients from adjuvant therapy: derived and validated in two population-based cohortsYudi Pawitan
Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden
Breast Cancer Res 7:R953-64. 2005..Breast cancer expression profiling has so far mainly been used to identify women with a poor prognosis as candidates for adjuvant therapy but without demonstrated value for therapy prediction...
The usefulness of a multidisciplinary educational programme after breast cancer surgery: a prospective and comparative studyIngaLill Koinberg
Department of Research 3D, Varberg Hospital, S 432 81 Varberg, Sweden
Eur J Oncol Nurs 10:273-82. 2006..A multidisciplinary educational programme may be an alternative to traditional follow-up by a physician after breast cancer surgery, but more research is needed about the financial benefits and effectiveness of such a programme...
Colorectal cancer survival in the Nordic countries and the United Kingdom: excess mortality risk analysis of 5 year relative period survival in the period 1999 to 2000Gerda Engholm
Department of Cancer Prevention and Documentation, Danish Cancer Society, Copenhagen, Denmark
Int J Cancer 121:1115-22. 2007..Use of more detailed age-intervals than conventionally applied in survival studies proved to be important in statistical modelling and is recommended for future studies...
[Insufficient studies of diagnostic cancer tests. Neither systematic review nor original studies come up to expectations]Lars Holmberg
Regionalt onkologiskt centrum, Akademiska sjukhuset, Uppsala
Lakartidningen 104:1308-9. 2007
Overexpression of cyclin E protein is associated with specific mutation types in the p53 gene and poor survival in human breast cancerThomas Lindahl
Department of Oncology and Pathology, Radiumhemmet, Karolinska Hospital and Institute R8 03, S 171 76 Stockholm, Sweden
Carcinogenesis 25:375-80. 2004..4, 95% confidence interval 1.3-4.5). In summary, our findings demonstrate that overexpression of cyclin E is associated with an aggressive tumor phenotype and specific types of p53 mutations...
[Quicker reporting to the Cancer Registry is required, according to a new regulation]Lotti Barlow
Epidemiologiskt centrum, Socialstyrelsen, Stockholm
Lakartidningen 100:3152-4. 2003
[A unique cooperation between trials on hormone replacement therapy following breast cancer]Lars Holmberg
Lakartidningen 100:2317. 2003
Absolute risk reductions for local recurrence after postoperative radiotherapy after sector resection for ductal carcinoma in situ of the breastLars Holmberg
Division of Cancer Studies, Thomas Guy House, 3rd Floor, King s College London, Guy s Campus, London SE1 9RT, United Kingdom
J Clin Oncol 26:1247-52. 2008..Evaluate the effects of radiotherapy after sector resection for ductal carcinoma in situ of the breast (DCIS) in patient groups as defined by age, size of the lesion, focality, completeness of excision and mode of detection...
Quality of life after radical prostatectomy or watchful waitingGunnar Steineck
Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden
N Engl J Med 347:790-6. 2002..We evaluated symptoms and self-assessments of quality of life in men with localized prostate cancer who participated in a randomized comparison between radical prostatectomy and watchful waiting...
A randomized trial comparing radical prostatectomy with watchful waiting in early prostate cancerLars Holmberg
Regional Oncologic Center, University Hospital, Uppsala, Sweden
N Engl J Med 347:781-9. 2002..41 to 0.96). CONCLUSIONS: In this randomized trial, radical prostatectomy significantly reduced disease-specific mortality, but there was no significant difference between surgery and watchful waiting in terms of overall survival...
The impact of organized mammography service screening on breast carcinoma mortality in seven Swedish countiesStephen W Duffy
Department of Mathematics, Statistics and Epidemiology, Cancer Research UK, PO Box 123, Lincoln s Inn Fields, London WC2A 3PX, United Kingdom
Cancer 95:458-69. 2002..e., nonattenders) after the initiation of organized screening...
Breast cancer patients' satisfaction with a spontaneous system of check-up visits to a specialist nurseInga Lill Koinberg
Oncology Clinic, Varberg Hospital, Varberg, Sweden
Scand J Caring Sci 16:209-15. 2002..To describe breast cancer patients' satisfaction with a spontaneous system of check-up visits to a specialist nurse...
Neoadjuvant cisplatin-methotrexate chemotherapy for invasive bladder cancer -- Nordic cystectomy trial 2Amir Sherif
Department of Urology, Akademiska University Hospital, Uppsala, Sweden
Scand J Urol Nephrol 36:419-25. 2002..CONCLUSIONS: The chemotherapy regimen was well tolerated. Despite substantial downstaging no statistically significant survival benefit with the neoadjuvant therapy could be seen after 5 years of follow-up...
